Misuse Of Vicks® Vaporub® May Harm Infants And Toddlers |
Toddler in Respiratory Distress After Popular Salve Used |
NORTHBROOK, IL — Vicks® VapoRub®, the popular salve used to relieve symptoms of cough and congestion, may be harmful for infants and toddlers. |
New research appearing in the
January issue of CHEST, the peer-reviewed journal of the American
College of Chest Physicians (ACCP), shows that Vicks® VapoRub® (VVR) may
stimulate mucus production and airway inflammation, which can have severe
effects on breathing in an infant or toddler. Research findings are consistent
with current VVR labeling which indicates the product should not be used on
children under 2 years of age. “The ingredients in Vicks can be irritants,
causing the body to produce more mucus to protect the airway,” said Bruce K.
Rubin, MD, FCCP, the study’s lead author from the Department of Pediatrics at
Wake Forest University School of Medicine, Winston Salem, NC. “Infants and young
children have airways that are much narrower than those of adults, so any
increase in mucus or inflammation can narrow them more severely.” |
|
Dr. Rubin and his colleagues at Wake Forest
became interested in the effects of VVR on small children after they cared for
an 18-month-old girl who developed severe respiratory distress after VVR was put
directly under her nose. The research team then launched an investigation to
determine the effects of VVR on the respiratory system. Using ferrets, which
have an airway anatomy and cellular composition similar to humans, the team
conducted tests that measured the effects of VVR on mucus secretion and build up
in the airways, and fluid build up in the lungs. Healthy ferrets and ferrets who
had induced tracheal inflammation (simulating a person with a chest infection)
underwent testing after they were exposed to VVR through intubation. Results showed that in vitro VVR
exposure increased mucus secretion 59 percent over baseline, while in vivo VVR
exposure increased mucus secretion 14 percent in normal airways and 8 percent in
the inflamed airway, in addition to the increase in secretion due to the
inflammation. Mucus clearance, as measured by ciliary beat frequency in the
trachea, also decreased by 36 percent during in vitro testing.
VVR is not indicated for patients under age 2.
However, Dr. Rubin realizes that some parents are still choosing to use VVR to
relieve their sick young child’s symptoms, usually rubbing the salve on the feet
or chest. “I recommend never putting Vicks in, or under,
the nose of anybody—adult or child. I also would follow the directions and never
use it at all in children under age 2,” said Dr. Rubin. Even when directions are
followed, VVR may make people with congestion feel more comfortable, but it does
nothing to increase airflow or actually relieve congestion. “Some of the
ingredients in Vicks, notably the menthol, trick the brain into thinking that it
is easier to breathe by triggering a cold sensation, which is processed as
indicating more airflow. Vicks may make you feel better but it can’t help you
breathe better.” Dr. Rubin also feels that although the study only tested Vick's
VapoRub, similar products, including generic brands, could cause the same
adverse reaction in infants and toddlers. In addition to VVR, decongestants are not
recommended for young children; however, there are other treatments that are
safe and effective. “Cough and cold medicines and decongestants are
dangerous and neither effective nor safe for young children. Medications to dry
up nasal passages also have problems,” said Dr. Rubin. “The best treatments for
congestion are a bit of saline (salt water) and gentle rubber bulb suction, warm
drinks or chicken soup, and, often, just letting the passage of time heal the
child.” Dr. Rubin also notes that if a child is struggling to breathe, it is a
medical emergency and would require the child to be seen by a doctor as quickly
as possible. “Parents should consult with a physician before
administering any over-the-counter medicine to infants and young children,” said
James A. L. Mathers, Jr., MD, FCCP, President of the American College of Chest
Physicians. “Furthermore, the American College of Chest Physicians and several
other health-care organizations have concluded that over-the-counter cough and
cold medicines can be harmful for infants and young children and are, therefore,
not recommended.” The ACCP represents 17,000 members who provide
patient care in the areas of pulmonary, critical care, and sleep medicine in the
United States and throughout the world. The ACCP’s mission is to promote the
prevention and treatment of diseases of the chest through leadership, education,
research, and communication. |
| Source: http://www.chestnet.org |
|
Copyright © 2003-2009 HealthOrbit, Inc. All rights reserved. |